DVA
DaVita·NYSE
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 3
Bearish signal 0
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DVA
Davita Inc.
A comprehensive kidney care provider that provides dialysis services to patients with end stage renal disease
Healthcare Providers and Services
--
11/03/1995
New York Stock Exchange
78,000
12-31
Common stock
2000 16th Street, Denver, CO 80202
--
DaVita Inc., was incorporated in Delaware in 1994. DaVita Inc.is a leading healthcare provider focused on transforming the delivery of care to improve the quality of life for patients around the world. As a comprehensive kidney care provider with more than 25 years of experience, DaVita provides services that support patients at every stage of their kidney health journey — from slowing the progression of kidney disease to facilitating transplantation. The company operates dialysis centers that support home care and provide services in hospitals and skilled nursing facilities. DaVita's commitment to innovation and integrated care aims to improve outcomes while minimizing costs, thereby strengthening its position as a trusted provider and partner in healthcare.
Company Financials
EPS
DVA has released its 2025 Q4 earnings. EPS was reported at 3.4, versus the expected 3.24, beating expectations. The chart below visualizes how DVA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
DVA has released its 2025 Q4 earnings report, with revenue of 3.62B, reflecting a YoY change of 9.87%, and net profit of 331.03M, showing a YoY change of -5.22%. The Sankey diagram below clearly presents DVA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
